The study included 1,373 women in six urban clinics. During the trial, women seeking abortions were asked to choose between surgical and medical abortion. In all three countries, more women chose medical over surgical abortion. The majority of women were satisfied or highly satisfied with their abortion experience, regardless of the method. Enthusiasm for the medical abortion method was particularly high.
Medical abortion is a revolutionary technique.
After months of negotiations and litigation, a new company, called Advances for Choice, has been established to market mifepristone in the United States and eventually worldwide. This company will take over the distribution rights previously awarded to businessman Joseph Pike. Advances for Health Technology and the Population Council filed a lawsuit against Pike in October in U.S. District Court in New York. The new firm will be headed by Jack Van Hulst, a former executive at Akzo, a Dutch pharmaceutical company, and will be located in New York City. The firm will assume the mission and responsibilities previously assigned to Advances in Health Technology, which has now been dissolved.